3647 results for «440»

Filter By

3647 results

Hotline - Mitral and tricuspid valvular interventions

16 Nov 2025 – From PCR London Valves 2025

This session delves into innovative mitral and tricuspid valvular interventions, highlighting outcomes with the PASCAL precision system and advances in combined MitraClip and TriClip repairs. It discusses predictors of heart failure hospitalization post-transcatheter tricuspid valve repair (TTVR), coronary CT-based pacemaker implantation prediction, and novel devices aimed...

Shaping the future: top innovations at PCR London Valves 2025

16 Nov 2025 – From PCR London Valves 2025

Highlighting transformative innovations from PCR London Valves 2025, this session features advanced technologies such as the Luna TMVR with its unique intuitive design, the novel Tripair technology for tricuspid therapy, and insights into right heart remodeling following transcatheter tricuspid valve interventions with the DUO system, showcasing...

Featured research - Tricuspid valve interventions - Part 2

16 Nov 2025 – From PCR London Valves 2025

This session highlights recent advances in tricuspid valve interventions with a focus on complex clinical scenarios. Topics include percutaneous annuloplasty as a bridge to edge-to-edge repair, long-term outcomes from the TriCLASP study, novel stratification methods to guide intervention, liver stiffness prognostics, right atrial remodeling post-repair, and...

Challenging TAVI

16 Nov 2025 – From PCR London Valves 2025

This session addresses the complexities encountered in transcatheter aortic valve implantation (TAVI) in challenging anatomical settings. It reviews management of bicuspid valves with calcification, horizontal aorta, coronary artery anomalies, and navigation of difficult angles. Case studies illustrate techniques to optimize commissural alignment and strategies to address...

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure

03 Feb 2022

Intravascular ultrasound-guided or angiography-guided complex high-risk PCI – The IVUS CHIP trial

28 Mar 2026

Daniele Giacoppo reports and provides his perspective on the main results of the IVUS-CHIP trial, presented by Roberto Diletti from the Erasmus University Medical Center, Rotterdam, the Netherlands, during a Late-Breaking Trials session at the ACC.26 in New Orleans, and simultaneously published in the New England Journal of...

Daniele Giacoppo

Author

Daniele Giacoppo
Intravascular ultrasound guidance for complex high-risk indicated procedures – The Ivus Chip trial
Didn’t find what you were looking for?